Biotech Values

[DewDiligence]

winchem:

>> 40mg end of treatment 207 results appear to be comparable to Mexico trials. There clearly appears to be a dropoff in VA one month after treatment that was not seen during the Phase I/II after both 1 and 3 months in Mexico. The 10 mg results are poorer at all stages. These preliminary results point to the possible need for weekly doses at 40 mg levels to maintain effective treatment [emphasis added].<<

I think that’s a reasonable summary of the “207” data released to date. Your description is far more illuminating than Dr. Levitt’s half-truth that the “207” results are consistent with the Mexican trial. Regards, Dew